What amount sold does Shine Medical Technologies, Inc. report in Form D filings?

The latest linked filings report $83.7M sold across 5 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Shine Medical Technologies, Inc.'s most recent SEC filing?

Shine Medical Technologies, Inc.'s most recent Form D filing was on 2019-06-28.

How many investors does Shine Medical Technologies, Inc. have?

The most recent Form D filing lists 99 investor(s).

What type of securities does Shine Medical Technologies, Inc. offer?

Shine Medical Technologies, Inc.'s SEC Form D filings indicate equity offerings.

Shine Medical Technologies, Inc.

CIK: 0001514300·Other Health Care·JANESVILLE, WI·Corporation

Reported Sold

$83,703,984

Total Filings

Identified Offerings

Last Filed

Jun 28, 2019

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other Health Care industry

SEC EDGAR

Offering filing timeline

Jun 28, 2019Form D — New notice

Reported sold: $18,081,000 · Target: $30,000,000

Rule 506(b)·99 investors

Nov 29, 2018Form D — New notice

Reported sold: $17,958,673 · Target: $24,558,131

Rule 506(b)·122 investors

Sep 6, 2017Form D — New notice

Reported sold: $6,881,987 · Target: $15,500,000

Rule 506(b)·26 investors

Apr 3, 2017Form D/A — Amendment

Reported sold: $29,346,241 · Target: $30,034,972

Rule 506(b)·217 investors

Changed: Reported amount sold, Offering target, Reported investors, Sales commissions

Jan 13, 2017Form D/A — Amendment

Reported sold: $27,179,741 · Target: $29,034,972

Rule 506(b)·208 investors

Changed: Reported amount sold, Offering target, Reported investors

Jan 5, 2016Form D — New notice

Reported sold: $11,534,972 · Target: $11,534,972

Rule 506(b)·93 investors

Oct 19, 2012Form D/A — Amendment

Reported sold: $11,436,083 · Target: $11,436,083

Rule 506·15 investors

Changed: Reported amount sold

Mar 20, 2012Form D/A — Amendment

Reported sold: $5,436,083 · Target: $11,436,083

Rule 506·15 investors

Changed: Reported amount sold, Reported investors

Jun 14, 2011Form D/A — Amendment

Reported sold: $2,436,083 · Target: $11,436,083

Rule 506·13 investors

Changed: Reported amount sold, Offering target, Reported investors

Mar 3, 2011Form D — New notice

Reported sold: $1,394,000 · Target: $1,394,000

Rule 506·12 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

$455,000

Amendment Rate

50%

Latest reported sold across 5 identified offerings

$83,703,984

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Philip M. Halpern

Related Person

Appears on 6 filings

Donald Whelley

Related Person

Appears on 6 filings

Anton Asmuth

Related Person

Appears on 5 filings

Thomas Rockwell Mackie

Related Person

Appears on 5 filings

Gregory Richard Piefer

Related Person

Appears on 5 filings

Darin Janecek

Related Person

Appears on 3 filings

Richard H. Leazer

Related Person

Appears on 3 filings

Katrina Pitas

Related Person

Appears on 3 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Jun 28, 2019	New	$30,000,000	$18,081,000	99
Nov 29, 2018	New	$24,558,131	$17,958,673	122
Sep 6, 2017	New	$15,500,000	$6,881,987	26
Apr 3, 2017	Amendment	$30,034,972	$29,346,241	217
Jan 13, 2017	Amendment	$29,034,972	$27,179,741	208
Jan 5, 2016	New	$11,534,972	$11,534,972	93
Oct 19, 2012	Amendment	$11,436,083	$11,436,083	15
Mar 20, 2012	Amendment	$11,436,083	$5,436,083	15
Jun 14, 2011	Amendment	$11,436,083	$2,436,083	13
Mar 3, 2011	New	$1,394,000	$1,394,000	12

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Salus Scientific Corp.

Other Health Care

Offering target: $30,000,000

Filed Oct 22, 2026